Css LLC Bristol Myers Squibb CO Call Options Transaction History

Css LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$47.98 - $54.4 $719,700 - $816,000	-15,000 Reduced 75.0%	5,000 $271,000
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $969,599 - $1.16 Million	20,000 New	20,000 $1.03 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $4.76 Million - $5.24 Million	65,500 Added 935.71%	72,500 $5.58 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $404,180 - $458,010	7,000 New	7,000 $434,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.